-
Vishal Mega Mart
129.95 134.50(%) -
Reliance Industr
1,425.80 1,115.55(%) -
Infosys
1,647.70 2,006.80(%) -
Sterlite Tech.
119.00 119.00(%) -
HDFC Bank
1,919.55 1,588.50(%) -
Varun Beverages
469.50 419.40(%) -
ICICI Bank
1,417.60 1,101.00(%) -
TCS
3,522.30 4,585.90(%) -
Happiest Minds
674.00 955.00(%) -
Mazagon Dock
3,342.85 3,778.00(%) -
Garden Reach Sh.
3,205.00 3,528.00(%) -
Bharti Airtel
1,847.50 1,373.05(%) -
M & M
2,993.70 2,360.45(%) -
Kotak Mah. Bank
2,129.90 1,679.10(%) -
Tata Motors
672.00 542.55(%) -
Cochin Shipyard
2,244.10 2,977.10(%) -
Hind. Unilever
2,334.10 3,034.50(%) -
Sun Pharma.Inds.
1,641.40 1,461.40(%) -
St Bk of India
790.75 679.65(%) -
HCL Technologies
1,738.00 2,011.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Rossari Biotech Ltd Chemicals
- Indian Private
- BSE Code : 72633.0
- ISIN : INE02A801020
-
Today’s Low
676.10 -
Today’s High
689.00

-
Open
689.00 -
Perv Close
683.55 -
52W Low
569.00 -
52W High
972.70
Key Indicators
-
P/E(TTM)
33.05
-
Mar.Cap (₹Cr.)
3,755.79
-
Div & Yield %
0.07
-
Book Value(₹)
194.55
-
Debt-Equity Ratio
-0.76
-
AGM Date
17-Jun-2025
-
EPS
20.50
-
P/E Ratio
33.05
Financials Ratios
-
Debt-Equity Ratio
0.10
-
Mar.Cap (₹Cr.)
3,755.79
-
RONW (%)
13.32
-
ROCE (%)
18.16
Score Board
-
Equity (₹ in Cr.)
11.07
-
BV (₹)
194.60
-
Sales( ₹ in Cr.)
1,431.63
-
NP (in Cr.)
113.50
-
NP Var(%)
16.0
-
Div%
25.0
-
CPS (₹)
25.50
-
EPS (₹)
20.50
-
Traded Value (₹ in Lakhs)
3,750.81
-
52 Week High
972.70
-
52 Week Low
569.00
-
Price BSE
677.0
-
Price NSE
678.00
-
Market Capital( in Cr.)
3,750.81
-
P/C Ratio
26.50
-
P/E Ratio
33.00
-
Price Vs.BV
20.50
-
31-May-2025( 03:06)
Corporate News - Rossa... - Rossari Biotech announced tha...
-
28-Apr-2025( 11:25)
Hot Pursuit - Rossa... - However, revenue from operatio...
-
26-Apr-2025( 07:32)
Results - Announcements - Rossa... - Net profit of Rossari Biotech...
-
26-Apr-2025( 07:31)
Results - Announcements - Rossa... - Net profit of Rossari Biotech...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,431.63 | 1,202.91 | 975.17 | 1,072.84 | 690.41 | 600.09 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,431.63 | 1,202.91 | 975.17 | 1,072.84 | 690.41 | 600.09 |
Other Income | 5.74 | 6.77 | 3.60 | 12.70 | 9.72 | 3.63 |
Stock Adjustments | 17.04 | 13.58 | 12.97 | 10.34 | 7.22 | -2.44 |
Total Income | 1,454.41 | 1,223.26 | 991.74 | 1,095.88 | 707.35 | 601.28 |
EXPENDITURE : | ||||||
Raw Materials | 1,064.12 | 910.72 | 717.28 | 833.02 | 458.86 | 369.26 |
Power and Fuel Cost | 3.41 | 3.01 | 2.80 | 2.80 | 2.40 | 1.74 |
Employee Cost | 60.01 | 51.46 | 57.35 | 43.53 | 36.66 | 37.13 |
Other Manufacturing Expenses | 71.29 | 44.25 | 38.04 | 37.50 | 27.75 | 26.64 |
Selling and Administration Expenses | 61.24 | 39.64 | 42.23 | 33.49 | 37.96 | 50.71 |
Miscellaneous Expenses | 2.36 | 6.14 | 7.80 | 10.05 | 12.67 | 7.16 |
Employee Benefit Expenses | 60.01 | 51.46 | 57.35 | 43.53 | 36.66 | 37.13 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,262.44 | 1,055.23 | 865.49 | 960.39 | 576.29 | 492.65 |
Operating Profit | 191.97 | 168.02 | 126.25 | 135.50 | 131.06 | 108.64 |
Interest | 9.58 | 9.70 | 4.62 | 2.55 | 2.99 | 3.68 |
Gross Profit | 182.39 | 158.32 | 121.63 | 132.95 | 128.07 | 104.96 |
Depreciation | 27.69 | 24.19 | 25.98 | 26.27 | 22.07 | 16.85 |
Profit Before Tax | 154.70 | 134.13 | 95.65 | 106.68 | 106.00 | 88.11 |
Current Tax | 42.19 | 36.16 | 25.97 | 28.72 | 27.53 | 23.80 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -2.23 | -1.67 | -1.71 | -1.51 | -0.63 | -1.22 |
Reported Net Profit | 114.74 | 99.65 | 71.39 | 79.47 | 79.10 | 65.52 |
Extraordinary Items | 1.24 | 2.20 | 0.42 | 1.42 | 0.32 | -0.05 |
Adjusted Net Profit | 113.50 | 97.45 | 70.97 | 78.05 | 78.78 | 65.57 |
Adjustment below Net Profit | -0.28 | -0.01 | 0.34 | 0.01 | 0.13 | -5.51 |
P & L Balance brought forward | 476.98 | 380.11 | 311.13 | 234.40 | 157.71 | 100.34 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 2.77 | 2.76 | 2.75 | 2.75 | 2.54 | 2.65 |
P & L Balance carried down | 588.68 | 476.98 | 380.11 | 311.13 | 234.40 | 157.71 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
Dividend Per Share(Rs) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
Earnings Per Share-Unit Curr | 20.72 | 18.04 | 12.94 | 14.44 | 15.23 | 12.91 |
Earnings Per Share(Adj)-Unit Curr | 20.72 | 18.04 | 12.94 | 14.44 | 15.23 | - |
Book Value | 194.56 | 173.83 | 155.69 | 142.50 | 77.88 | 55.85 |
Book Value(Adj)-Unit Curr | 194.56 | 173.83 | 155.69 | 142.50 | 77.88 | - |